SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.170-2.9%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheeseburger who wrote (771)8/25/1999 7:24:00 PM
From: G-MAN  Read Replies (1) of 900
 
I'm wondering if anyone has any opinions to the following questions?

1.) Is there a chance that the current price already reflects a favorable ruling from the FDA Advisory Committee? (The current weakness in the stock with three weeks to go is making me wonder.) Each day this week the stock shows some strength for the first hour or so, and then it tanks.

2) If not, does anyone have a reasonable conjecture as to why the price has been slipping all week?

3) Most of the opinions I have read point to the possibility of a favorable opinion being the probable outcome vs an unfavorable opinion on Evacet. In addition, the company has entered into two recent deals to test Evacet with other cancer fighting drugs. My thought is this: "If Evacet was not effective in a positive way, would they be entering into these deals with other pharmas? Does anyone have any opinions as to whether the two recent deals are at all correlated with the results of the trials being presented to the FDA?

4) Are there any TA's out there with any price projections?

5) Are there any political issues that surround this drug submittal and the FDA?

Thanks in advance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext